{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:31:52Z","timestamp":1791156712330,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2010,9,19]],"date-time":"2010-09-19T00:00:00Z","timestamp":1284854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Neurosci"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1038\/nn.2632","type":"journal-article","created":{"date-parts":[[2010,9,19]],"date-time":"2010-09-19T14:04:32Z","timestamp":1284905072000},"page":"1265-1270","source":"Crossref","is-referenced-by-count":314,"title":["Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism"],"prefix":"10.1038","volume":"13","author":[{"given":"Jason R","family":"Clapper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Moreno-Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Guijarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Vacondio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Duranti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Tontini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvano","family":"Sanchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natale R","family":"Sciolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M","family":"Spradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea G","family":"Hohmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Calignano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Mor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Tarzia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Piomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,19]]},"reference":[{"key":"BFnn2632_CR1","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/nm908","volume":"9","author":"C Stein","year":"2003","unstructured":"Stein, C., Schafer, M. & Machelska, H. Attacking pain at its source: new perspectives on opioids. Nat. Med. 9, 1003\u20131008 (2003).","journal-title":"Nat. Med."},{"key":"BFnn2632_CR2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/28393","volume":"394","author":"A Calignano","year":"1998","unstructured":"Calignano, A., La Rana, G., Giuffrida, A. & Piomelli, D. Control of pain initiation by endogenous cannabinoids. Nature 394, 277\u2013281 (1998).","journal-title":"Nature"},{"key":"BFnn2632_CR3","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S0306-4522(02)00870-9","volume":"117","author":"AG Nackley","year":"2003","unstructured":"Nackley, A.G., Suplita, R.L. II & Hohmann, A.G. A peripheral cannabinoid mechanism suppresses spinal fos protein expression and pain behavior in a rat model of inflammation. Neuroscience 117, 659\u2013670 (2003).","journal-title":"Neuroscience"},{"key":"BFnn2632_CR4","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1021\/jm070317a","volume":"50","author":"EK Dziadulewicz","year":"2007","unstructured":"Dziadulewicz, E.K. et al. Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone: a potent, orally bioavailable human CB1\/CB2 dual agonist with antihyperalgesic properties and restricted central nervous system penetration. J. Med. Chem. 50, 3851\u20133856 (2007).","journal-title":"J. Med. Chem."},{"key":"BFnn2632_CR5","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.brainresrev.2008.12.003","volume":"60","author":"P Anand","year":"2009","unstructured":"Anand, P., Whiteside, G., Fowler, C.J. & Hohmann, A.G. Targeting CB2 receptors and the endocannabinoid system for the treatment of pain. Brain Res. Rev. 60, 255\u2013266 (2009).","journal-title":"Brain Res. Rev."},{"key":"BFnn2632_CR6","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/nn1916","volume":"10","author":"N Agarwal","year":"2007","unstructured":"Agarwal, N. et al. Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nat. Neurosci. 10, 870\u2013879 (2007).","journal-title":"Nat. Neurosci."},{"key":"BFnn2632_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1159\/000235870","volume":"43","author":"I Kaufmann","year":"2009","unstructured":"Kaufmann, I. et al. Enhanced anandamide plasma levels in patients with complex regional pain syndrome following traumatic injury: a preliminary report. Eur. Surg. Res. 43, 325\u2013329 (2009).","journal-title":"Eur. Surg. Res."},{"key":"BFnn2632_CR8","doi-asserted-by":"publisher","first-page":"R43","DOI":"10.1186\/ar2401","volume":"10","author":"D Richardson","year":"2008","unstructured":"Richardson, D. et al. Characterization of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis. Arthritis Res. Ther. 10, R43 (2008).","journal-title":"Arthritis Res. Ther."},{"key":"BFnn2632_CR9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.pain.2006.06.016","volume":"126","author":"S Mitrirattanakul","year":"2006","unstructured":"Mitrirattanakul, S. et al. Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain. Pain 126, 102\u2013114 (2006).","journal-title":"Pain"},{"key":"BFnn2632_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1208\/s12248-008-9075-y","volume":"11","author":"JE Schlosburg","year":"2009","unstructured":"Schlosburg, J.E., Kinsey, S.G. & Lichtman, A.H. Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation. AAPS J. 11, 39\u201344 (2009).","journal-title":"AAPS J."},{"key":"BFnn2632_CR11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nm803","volume":"9","author":"S Kathuria","year":"2003","unstructured":"Kathuria, S. et al. Modulation of anxiety through blockade of anandamide hydrolysis. Nat. Med. 9, 76\u201381 (2003).","journal-title":"Nat. Med."},{"key":"BFnn2632_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1527-3458.2006.00021.x","volume":"12","author":"D Piomelli","year":"2006","unstructured":"Piomelli, D. et al. Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597). CNS Drug Rev. 12, 21\u201338 (2006).","journal-title":"CNS Drug Rev."},{"key":"BFnn2632_CR13","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/cmdc.200900210","volume":"4","author":"JR Clapper","year":"2009","unstructured":"Clapper, J.R. et al. A second generation of carbamate-based fatty acid amide hydrolase inhibitors with improved activity in vivo. ChemMedChem 4, 1505\u20131513 (2009).","journal-title":"ChemMedChem"},{"key":"BFnn2632_CR14","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.chembiol.2005.08.011","volume":"12","author":"JP Alexander","year":"2005","unstructured":"Alexander, J.P. & Cravatt, B.F. Mechanism of carbamate inactivation of FAAH: implications for the design of covalent inhibitors and in vivo functional probes for enzymes. Chem. Biol. 12, 1179\u20131187 (2005).","journal-title":"Chem. Biol."},{"key":"BFnn2632_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1602\/neurorx.2.1.86","volume":"2","author":"W L\u00f6scher","year":"2005","unstructured":"L\u00f6scher, W. & Potschka, H. Blood\u2013brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx 2, 86\u201398 (2005).","journal-title":"NeuroRx"},{"key":"BFnn2632_CR16","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1124\/mol.64.3.610","volume":"64","author":"Y Imai","year":"2003","unstructured":"Imai, Y. et al. Breast cancer resistance protein exports sulfated estrogens, but not free estrogens. Mol. Pharmacol. 64, 610\u2013618 (2003).","journal-title":"Mol. Pharmacol."},{"key":"BFnn2632_CR17","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/j.lfs.2005.05.012","volume":"77","author":"J LoVerme","year":"2005","unstructured":"LoVerme, J., La Rana, G., Russo, R., Calignano, A. & Piomelli, D. The search for the palmitoylethanolamide receptor. Life Sci. 77, 1685\u20131698 (2005).","journal-title":"Life Sci."},{"key":"BFnn2632_CR18","doi-asserted-by":"publisher","first-page":"9371","DOI":"10.1073\/pnas.161191698","volume":"98","author":"BF Cravatt","year":"2001","unstructured":"Cravatt, B.F. et al. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc. Natl. Acad. Sci. USA 98, 9371\u20139376 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnn2632_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.pharmthera.2007.01.005","volume":"114","author":"K Starowicz","year":"2007","unstructured":"Starowicz, K., Nigam, S. & Di Marzo, V. Biochemistry and pharmacology of endovanilloids. Pharmacol. Ther. 114, 13\u201333 (2007).","journal-title":"Pharmacol. Ther."},{"key":"BFnn2632_CR20","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1124\/jpet.106.111385","volume":"319","author":"J LoVerme","year":"2006","unstructured":"LoVerme, J. et al. Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor alpha. J. Pharmacol. Exp. Ther. 319, 1051\u20131061 (2006).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnn2632_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ejphar.2007.03.007","volume":"566","author":"R Russo","year":"2007","unstructured":"Russo, R. et al. Synergistic antinociception by the cannabinoid receptor agonist anandamide and the PPAR alpha receptor agonist GW7647. Eur. J. Pharmacol. 566, 117\u2013119 (2007).","journal-title":"Eur. J. Pharmacol."},{"key":"BFnn2632_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","volume":"33","author":"GJ Bennett","year":"1988","unstructured":"Bennett, G.J. & Xie, Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33, 87\u2013107 (1988).","journal-title":"Pain"},{"key":"BFnn2632_CR23","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1124\/jpet.107.119941","volume":"322","author":"R Russo","year":"2007","unstructured":"Russo, R. et al. The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3\u2032-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice. J. Pharmacol. Exp. Ther. 322, 236\u2013242 (2007).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnn2632_CR24","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.1523\/JNEUROSCI.12-09-03665.1992","volume":"12","author":"TJ Coderre","year":"1992","unstructured":"Coderre, T.J. & Melzack, R. The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J. Neurosci. 12, 3665\u20133670 (1992).","journal-title":"J. Neurosci."},{"key":"BFnn2632_CR25","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/0304-3959(95)00121-2","volume":"64","author":"S Puig","year":"1996","unstructured":"Puig, S. & Sorkin, L.S. Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity. Pain 64, 345\u2013355 (1996).","journal-title":"Pain"},{"key":"BFnn2632_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tips.2008.10.001","volume":"30","author":"G Kunos","year":"2009","unstructured":"Kunos, G., Osei\u2013Hyiaman, D., Batkai, S., Sharkey, K.A. & Makriyannis, A. Should peripheral CB(1) cannabinoid receptors be selectively targeted for therapeutic gain? Trends Pharmacol. Sci. 30, 1\u20137 (2009).","journal-title":"Trends Pharmacol. Sci."},{"key":"BFnn2632_CR27","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1046\/j.1471-4159.2003.01550.x","volume":"84","author":"J Ahluwalia","year":"2003","unstructured":"Ahluwalia, J., Yaqoob, M., Urban, L., Bevan, S. & Nagy, I. Activation of capsaicin-sensitive primary sensory neurones induces anandamide production and release. J. Neurochem. 84, 585\u2013591 (2003).","journal-title":"J. Neurochem."},{"key":"BFnn2632_CR28","doi-asserted-by":"publisher","first-page":"13345","DOI":"10.1073\/pnas.0601832103","volume":"103","author":"J Liu","year":"2006","unstructured":"Liu, J. et al. A biosynthetic pathway for anandamide. Proc. Natl. Acad. Sci. USA 103, 13345\u201313350 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnn2632_CR29","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/S0306-4522(98)00524-7","volume":"90","author":"AG Hohmann","year":"1999","unstructured":"Hohmann, A.G. & Herkenham, M. Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study. Neuroscience 90, 923\u2013931 (1999).","journal-title":"Neuroscience"},{"key":"BFnn2632_CR30","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S0306-4522(99)00220-1","volume":"92","author":"AG Hohmann","year":"1999","unstructured":"Hohmann, A.G. & Herkenham, M. Cannabinoid receptors undergo axonal flow in sensory nerves. Neuroscience 92, 1171\u20131175 (1999).","journal-title":"Neuroscience"},{"key":"BFnn2632_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0304-3959(97)00213-3","volume":"75","author":"JD Richardson","year":"1998","unstructured":"Richardson, J.D., Kilo, S. & Hargreaves, K.M. Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. Pain 75, 111\u2013119 (1998).","journal-title":"Pain"},{"key":"BFnn2632_CR32","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/sj.bjp.0707531","volume":"153","author":"J Guindon","year":"2008","unstructured":"Guindon, J. & Hohmann, A.G. Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain. Br. J. Pharmacol. 153, 319\u2013334 (2008).","journal-title":"Br. J. Pharmacol."},{"key":"BFnn2632_CR33","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/bjp.2008.335","volume":"155","author":"DR Sagar","year":"2008","unstructured":"Sagar, D.R., Kendall, D.A. & Chapman, V. Inhibition of fatty acid amide hydrolase produces PPAR alpha\u2013mediated analgesia in a rat model of inflammatory pain. Br. J. Pharmacol. 155, 1297\u20131306 (2008).","journal-title":"Br. J. Pharmacol."},{"key":"BFnn2632_CR34","doi-asserted-by":"publisher","first-page":"10821","DOI":"10.1073\/pnas.0401292101","volume":"101","author":"BF Cravatt","year":"2004","unstructured":"Cravatt, B.F. et al. Functional disassociation of the central and peripheral fatty acid amide signaling systems. Proc. Natl. Acad. Sci. USA 101, 10821\u201310826 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnn2632_CR35","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1523\/JNEUROSCI.4071-08.2009","volume":"29","author":"IJ Lever","year":"2009","unstructured":"Lever, I.J. et al. Localization of the endocannabinoid-degrading enzyme fatty acid amide hydrolase in rat dorsal root ganglion cells and its regulation after peripheral nerve injury. J. Neurosci. 29, 3766\u20133780 (2009).","journal-title":"J. Neurosci."},{"key":"BFnn2632_CR36","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/978-3-540-79090-7_14","volume":"194","author":"C Stein","year":"2009","unstructured":"Stein, C. & Zollner, C. Opioids and sensory nerves. Handb. Exp. Pharmacol. 194, 495\u2013518 (2009).","journal-title":"Handb. Exp. Pharmacol."},{"key":"BFnn2632_CR37","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1093\/brain\/awg115","volume":"126","author":"I Tegeder","year":"2003","unstructured":"Tegeder, I. et al. Peripheral opioid analgesia in experimental human pain models. Brain 126, 1092\u20131102 (2003).","journal-title":"Brain"},{"key":"BFnn2632_CR38","doi-asserted-by":"publisher","first-page":"4998","DOI":"10.1021\/jm031140x","volume":"47","author":"M Mor","year":"2004","unstructured":"Mor, M. et al. Cyclohexylcarbamic acid 3\u2032- or 4\u2032-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure\u2013activity relationships, and molecular modeling studies. J. Med. Chem. 47, 4998\u20135008 (2004).","journal-title":"J. Med. Chem."},{"key":"BFnn2632_CR39","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.chembiol.2007.10.017","volume":"14","author":"AR King","year":"2007","unstructured":"King, A.R. et al. URB602 inhibits monoacylglycerol lipase and selectively blocks 2-arachidonoylglycerol degradation in intact brain slices. Chem. Biol. 14, 1357\u20131365 (2007).","journal-title":"Chem. Biol."},{"key":"BFnn2632_CR40","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1194\/jlr.M700354-JLR200","volume":"49","author":"G Astarita","year":"2008","unstructured":"Astarita, G., Ahmed, F. & Piomelli, D. Identification of biosynthetic precursors for the endocannabinoid anandamide in the rat brain. J. Lipid Res. 49, 48\u201357 (2008).","journal-title":"J. Lipid Res."},{"key":"BFnn2632_CR41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0014-2999(01)00988-8","volume":"419","author":"A Calignano","year":"2001","unstructured":"Calignano, A., La Rana, G. & Piomelli, D. Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide. Eur. J. Pharmacol. 419, 191\u2013198 (2001).","journal-title":"Eur. J. Pharmacol."},{"key":"BFnn2632_CR42","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0304-3959(92)90003-T","volume":"51","author":"A Tj\u00f8lsen","year":"1992","unstructured":"Tj\u00f8lsen, A., Berge, O.G., Hunskaar, S., Rosland, J.H. & Hole, K. The formalin test: an evaluation of the method. Pain 51, 5\u201317 (1992).","journal-title":"Pain"}],"container-title":["Nature Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nn.2632.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nn.2632","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nn.2632.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:06:26Z","timestamp":1684440386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nn.2632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,19]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["BFnn2632"],"URL":"https:\/\/doi.org\/10.1038\/nn.2632","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.5770962.5753061","asserted-by":"object"}]},"ISSN":["1097-6256","1546-1726"],"issn-type":[{"value":"1097-6256","type":"print"},{"value":"1546-1726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,19]]}}}